human umbilical vascular ecs huvecs Search Results


90
Pasteur Institute normal huvec
(A, B) The cell viability percentage of Rova-GrB and Rova-Typh <t>on</t> <t>A549</t> and <t>HUVEC</t> cell lines after 24 h of incubation (The control group is without Rova-GrB and Rova-Typh). The significance of the results (p-Value) between the control group and other groups has been indicated as follows: *P < 0.05; **P < 0.01; **P < 0.001.
Normal Huvec, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal huvec/product/Pasteur Institute
Average 90 stars, based on 1 article reviews
normal huvec - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ScienCell huvec sciencell-1800
(A, B) The cell viability percentage of Rova-GrB and Rova-Typh <t>on</t> <t>A549</t> and <t>HUVEC</t> cell lines after 24 h of incubation (The control group is without Rova-GrB and Rova-Typh). The significance of the results (p-Value) between the control group and other groups has been indicated as follows: *P < 0.05; **P < 0.01; **P < 0.001.
Huvec Sciencell 1800, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/huvec sciencell-1800/product/ScienCell
Average 90 stars, based on 1 article reviews
huvec sciencell-1800 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prism 5.01 software
(A, B) The cell viability percentage of Rova-GrB and Rova-Typh <t>on</t> <t>A549</t> and <t>HUVEC</t> cell lines after 24 h of incubation (The control group is without Rova-GrB and Rova-Typh). The significance of the results (p-Value) between the control group and other groups has been indicated as follows: *P < 0.05; **P < 0.01; **P < 0.001.
Prism 5.01 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism 5.01 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism 5.01 software - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics huvec complete growth medium icell–h110–001b
(A, B) The cell viability percentage of Rova-GrB and Rova-Typh <t>on</t> <t>A549</t> and <t>HUVEC</t> cell lines after 24 h of incubation (The control group is without Rova-GrB and Rova-Typh). The significance of the results (p-Value) between the control group and other groups has been indicated as follows: *P < 0.05; **P < 0.01; **P < 0.001.
Huvec Complete Growth Medium Icell–H110–001b, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/huvec complete growth medium icell–h110–001b/product/iCell Gene Therapeutics
Average 90 stars, based on 1 article reviews
huvec complete growth medium icell–h110–001b - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Millipore human umbilical artery endothelial cells
Effect of EGCG-treated apoA-I fibrils on the viability of <t>human</t> <t>umbilical</t> <t>artery</t> <t>endothelial</t> <t>cells.</t> A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.
Human Umbilical Artery Endothelial Cells, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human umbilical artery endothelial cells/product/Millipore
Average 90 stars, based on 1 article reviews
human umbilical artery endothelial cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Evercyte Inc immortalized human umbilical vein endothelial cells (huvectert2)
Effect of EGCG-treated apoA-I fibrils on the viability of <t>human</t> <t>umbilical</t> <t>artery</t> <t>endothelial</t> <t>cells.</t> A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.
Immortalized Human Umbilical Vein Endothelial Cells (Huvectert2), supplied by Evercyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immortalized human umbilical vein endothelial cells (huvectert2)/product/Evercyte Inc
Average 90 stars, based on 1 article reviews
immortalized human umbilical vein endothelial cells (huvectert2) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lonza human umbilical vein endothelial cells (huvec
Effect of EGCG-treated apoA-I fibrils on the viability of <t>human</t> <t>umbilical</t> <t>artery</t> <t>endothelial</t> <t>cells.</t> A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.
Human Umbilical Vein Endothelial Cells (Huvec, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human umbilical vein endothelial cells (huvec/product/Lonza
Average 90 stars, based on 1 article reviews
human umbilical vein endothelial cells (huvec - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lonza huvecs
Effect of EGCG-treated apoA-I fibrils on the viability of <t>human</t> <t>umbilical</t> <t>artery</t> <t>endothelial</t> <t>cells.</t> A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.
Huvecs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/huvecs/product/Lonza
Average 90 stars, based on 1 article reviews
huvecs - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lonza huvecs lonza
Effect of EGCG-treated apoA-I fibrils on the viability of <t>human</t> <t>umbilical</t> <t>artery</t> <t>endothelial</t> <t>cells.</t> A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.
Huvecs Lonza, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/huvecs lonza/product/Lonza
Average 90 stars, based on 1 article reviews
huvecs lonza - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lonza human umbilical vein endothelial cells (huvec)
Effect of EGCG-treated apoA-I fibrils on the viability of <t>human</t> <t>umbilical</t> <t>artery</t> <t>endothelial</t> <t>cells.</t> A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.
Human Umbilical Vein Endothelial Cells (Huvec), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human umbilical vein endothelial cells (huvec)/product/Lonza
Average 90 stars, based on 1 article reviews
human umbilical vein endothelial cells (huvec) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lonza human umbilical artery vsmcs
Effect of EGCG-treated apoA-I fibrils on the viability of <t>human</t> <t>umbilical</t> <t>artery</t> <t>endothelial</t> <t>cells.</t> A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.
Human Umbilical Artery Vsmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human umbilical artery vsmcs/product/Lonza
Average 90 stars, based on 1 article reviews
human umbilical artery vsmcs - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lifeline Cell Technology huvecs
Effect of EGCG-treated apoA-I fibrils on the viability of <t>human</t> <t>umbilical</t> <t>artery</t> <t>endothelial</t> <t>cells.</t> A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.
Huvecs, supplied by Lifeline Cell Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/huvecs/product/Lifeline Cell Technology
Average 90 stars, based on 1 article reviews
huvecs - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


(A, B) The cell viability percentage of Rova-GrB and Rova-Typh on A549 and HUVEC cell lines after 24 h of incubation (The control group is without Rova-GrB and Rova-Typh). The significance of the results (p-Value) between the control group and other groups has been indicated as follows: *P < 0.05; **P < 0.01; **P < 0.001.

Journal: Frontiers in Molecular Biosciences

Article Title: Comparison of two immunotoxins against DLL3 receptor; as an inhibitor for small cell lung cancer

doi: 10.3389/fmolb.2025.1506768

Figure Lengend Snippet: (A, B) The cell viability percentage of Rova-GrB and Rova-Typh on A549 and HUVEC cell lines after 24 h of incubation (The control group is without Rova-GrB and Rova-Typh). The significance of the results (p-Value) between the control group and other groups has been indicated as follows: *P < 0.05; **P < 0.01; **P < 0.001.

Article Snippet: The human A549 lung cancer cell lines and the normal HUVEC, Human umbilical vein endothelial cell line, were purchased from the Pasteur Institute and Iranian Biological Resource Center (IBRC), respectively.

Techniques: Incubation, Control

Effect of EGCG-treated apoA-I fibrils on the viability of human umbilical artery endothelial cells. A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.

Journal: The Journal of Biological Chemistry

Article Title: Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin

doi: 10.1074/jbc.RA118.002038

Figure Lengend Snippet: Effect of EGCG-treated apoA-I fibrils on the viability of human umbilical artery endothelial cells. A, effect on cell viability of apoA-I fibrils after exposure to different concentrations of EGCG. B, effect on cell viability of apoA-I fibrils formed in the presence of heparin after exposure to different concentrations of EGCG. C, control measurements of cell viability after the addition of heparin, EGCG, or a mixture of both. Means and standard errors are shown for n = 5 for each sample group except for the control cells only, for which n = 15. D, release of heparin from apoA-I fibrils into aqueous solution by the addition of different concentrations of EGCG. Fibrils were formed from 36 μ m apoA-I in the presence of 72 μ m heparin doped with 1% w/w fluorescein heparin conjugate, which was detected by absorbance at 495 nm.

Article Snippet: Human umbilical artery endothelial cells (Sigma) were plated on 96-well plates at a cell density of ∼5000 cells per well and grown overnight at 37 °C to allow the cells to adhere.

Techniques: